brain Logo
DE
  • 61

    Nature's biodiversity is the source of our innovation: microorganisms and their enzymes open up unique opportunities for us to develop sustainable and scalable solutions for tomorrow's markets.

    • Company
    • Goals & Values
    • Management
      • Products & Services
      • Enzymes, Microorganisms & Ingredients
      • R&D Services
      • Fermentation Services
      • Sites
      • Production, Blending & Distribution
      • R&D Services
      • Markets
      • Life Science & Pharma
      • Food & Beverages
      • Environmental
    • Pipeline
    • Corporate History
    • Contact
  • 131

    We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.

    • Investors
      • BRAIN Biotech AG at a Glance
      • Strategy
      • Key financial figures
      • Segments
    • Why invest
      • Corporate Governance
      • Management & Control
      • Executive Management Board
      • Supervisory Board
      • Declaration on corporate governance
      • Statement of conformity 2025
      • Compensation
      • Articles of Association and Rules of Procedure of the Supervisory Board
      • Financial Publications & Calendar
      • Financial and Corporate News
      • Financial Reports
      • Presentations & Videos
      • Financial Calendar
      • Investor Events
      • Capital Markets Day
      • Glossary
    • Share
      • Annual General Meeting
      • Annual General Meeting 2026
      • Archive
    • FAQ
    • Request Information
  • 163

    We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.

    • Sustainability
    • Our Approach
    • ESG-Strategie auf einen Blick
    • Environment
    • Social Responsibility
    • Corporate Management
    • Sustainability Reporting
    • Download Sustainability Report & ESG Fact Sheet
  • 155
    • News & Media
    • News & Stories
    • Press releases
    • Presentations & Videos
    • Press Contact
  • 171
    • Career
    • Working in the BRAIN Biotech Group
    • Apply for sites
    • Job vacancies in the BRAIN Biotech Group
DE
  • Home
  • News & Media
  • Press releases

Press Releases

25.05.2023
BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
Finance Corporate
Show Article
24.05.2023
BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
Corporate
Show Article
08.03.2023
Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
Corporate
Show Article
27.02.2023
BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
Finance
Show Article
27.02.2023
Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
Corporate
Show Article
22.02.2023
BRAIN Biotech and TransCode Therapeutics join forces
Technology
Show Article
08.02.2023
BRAIN Biotech und AMSilk kooperieren bei der Entwicklung leistungsfähiger biobasierter Proteinfasern
Technology Corporate
Show Article
08.02.2023
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
Technology
Show Article
16.01.2023
BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
Finance
Show Article
  • 1
  • 4
  • 5
  • 6
  • 9
BRAIN Biotech AG

Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

public@brain-biotech.com
Phone: +49 62 51 9331-0
Fax: +49 62 51 9331-11
www.brain-biotech-group.com
Copyright © 2026 BRAIN Biotech AG
Social Networks
Privacy Policy Imprint Contact
Legal aspects Cookie Settings